Article(id=1329527197683004077, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.05.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1700668800000, receivedDateStr=2023-11-23, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913585347, onlineDateStr=2026-11-17, pubDate=1715270400000, pubDateStr=2024-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913585347, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913585347, creator=13701087609, updateTime=1794913585347, updator=13701087609, issue=Issue{id=1329527047069741522, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='5', pageStart='449', pageEnd='566', issueExtLink='null', onlineDate='null', pubDate='1715270400000', pubDateStr='2024-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913549438, creator='13701087609', updateTime=1794962129197, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329730805833773281, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329730805833773282, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=549, endPage=554, ext={EN=ArticleExt(id=1329527199222313646, articleId=1329527197683004077, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances in the treatment of eosinophilia related diseases with mepolizumab, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

There are many eosinophilia-related diseases, with different etiologies and different therapeutic programs. The first-line treatment for non-infectious and non-tumor-related eosinophilia-related diseases is mostly glucocorticoids, which can be combined with immunosuppressive agents according to the severity of the disease. Mepolizumab is a human anti-interleukin-5 monoclonal antibody which has been approved by the FDA for second-line treatment for chronic sinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. This article reviewed the research progress of mepolizumab in the application of eosinophilia-related diseases except bronchial asthma.

, authors=Xuelan ZHANG, Xiaomeng YE, Jian ZHAO, Jing MENG, authorsList=Xuelan ZHANG, Xiaomeng YE, Jian ZHAO, Jing MENG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527199465583279, articleId=1329527197683004077, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=美泊利单抗在嗜酸性粒细胞增多疾病的治疗进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

嗜酸性粒细胞增多相关疾病较多,其病因不同,治疗方案也不相同,非感染和非肿瘤嗜酸性粒细胞增多相关疾病的一线治疗大多为糖皮质激素,根据病情轻重可联合免疫抑制剂治疗。美泊利单抗(mepolizumab)是一种人源抗白介素-5单克隆抗体,目前已被美国FDA批准用于慢性鼻-鼻窦炎伴鼻息肉(Chronic sinusitis with nasal polyps)、嗜酸性肉芽肿多血管炎(eosinophilic granulomatosis with polyangiitis)及高嗜酸性粒细胞综合征(hypereosinophilic syndrome)的二线治疗。现就美泊利单抗治疗除支气管哮喘(bronchial asthma)外相关嗜酸性粒细胞的应用研究进展作综述。

, authors=张学兰, 叶小萌, 赵健, 孟静, authorsList=张学兰, 叶小萌, 赵健, 孟静, authorCompany=null, correspAuthors=null, authorNote=

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=cNhotY9Td3oQsvgZa20MFA==, magXml=cOVn0ZeFTYhOIzYQSsuXuw==, pdfUrl=null, pdf=h693YmZXQP5JnQ1DGfzQUQ==, pdfFileSize=1525318, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=vi20rKBwhCP83GNnB6Bk5Q==, mapNumber=null, fund=null)}, authors=[Author(id=1329527199792738996, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527199968899766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527199792738996, language=EN, stringName=Xuelan ZHANG, firstName=Xuelan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200077951671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527199792738996, language=CN, stringName=张学兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio={"content":"

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

"}, bioImg=null, bioContent=

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200153449145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200237335227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200153449145, language=EN, stringName=Xiaomeng YE, firstName=Xiaomeng, middleName=null, lastName=YE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200312832700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200153449145, language=CN, stringName=叶小萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200413495998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200505770688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200413495998, language=EN, stringName=Jian ZHAO, firstName=Jian, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200593851073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200413495998, language=CN, stringName=赵健, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200665154243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200770011845, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200665154243, language=EN, stringName=Jing MENG, firstName=Jing, middleName=null, lastName=MENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200900035270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200665154243, language=CN, stringName=孟静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])])], keywords=[Keyword(id=1329527201000698567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=EN, orderNo=1, keyword=eosinophilia), Keyword(id=1329527201076196040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=EN, orderNo=2, keyword=mepolizumab), Keyword(id=1329527201155887817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=EN, orderNo=3, keyword=clinical application), Keyword(id=1329527201256551114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=CN, orderNo=1, keyword=嗜酸性粒细胞增多), Keyword(id=1329527201474654923, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=CN, orderNo=2, keyword=美泊利珠单抗), Keyword(id=1329527201566929612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, language=CN, orderNo=3, keyword=临床应用)], refs=[Reference(id=1329527201680175821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=王子熹. 嗜酸性粒细胞增多综合征的诊断与治疗[J]. 中华临床免疫与变态反应杂志, 2021, 15(1): 108-109., articleTitle=null, refAbstract=null), Reference(id=1329527201755673294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=夏训明. 美国FDA批准Nucala (mepolizumab/美泊利单抗)用于治疗嗜酸性粒细胞综合征[J]. 广东药科大学学报, 2020, 36(5): 746., articleTitle=null, refAbstract=null), Reference(id=1329527201847947983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Respir Med, 2021, 9(10): 1141-1153., articleTitle=null, refAbstract=null), Reference(id=1329527201927639760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis[J]. N Engl J Med, 2017, 376(20): 1921-1932., articleTitle=null, refAbstract=null), Reference(id=1329527203546641105, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Roufosse F, Kahn JE, Rothenberg ME, et al. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phaseⅢ, randomized, placebo-controlled trial[J]. J Allergy Clin Immunol, 2020, 146(6): 1397-1405., articleTitle=null, refAbstract=null), Reference(id=1329527203643110098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Pavord ID, Bel EH, Bourdin A, et al. From DREAM to REALITI-A and beyond: mepolizumab for the treatment of eosinophil-driven diseases[J]. Allergy, 2022, 77(3): 778-797., articleTitle=null, refAbstract=null), Reference(id=1329527203718607571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Fokkens WJ, Viskens AS, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023[J]. Rhinology, 2023, 61(3): 194-202., articleTitle=null, refAbstract=null), Reference(id=1329527203802493652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Bachert C, Sousa AR, Han JK, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count[J]. J Allergy Clin Immunol, 2022, 149(5): 1711-1721., articleTitle=null, refAbstract=null), Reference(id=1329527203877991125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Fokkens WJ, Mullol J, Kennedy D, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): in-depth sinus surgery analysis[J]. Allergy, 2023, 78(3): 812-821., articleTitle=null, refAbstract=null), Reference(id=1329527203957682902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Hopkins C, Han JK, Lund VJ, et al. Evaluating treatment response to mepolizumab in patients with severe CRSwNP[J]. Rhinology, 2023, 61(2): 108-117., articleTitle=null, refAbstract=null), Reference(id=1329527204037374679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016, 75(9): 1583-1594., articleTitle=null, refAbstract=null), Reference(id=1329527204171592408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Ennis D, Lee JK, Pagnoux C. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis[J]. Expert Opin Biol Ther, 2019, 19(7): 617-630., articleTitle=null, refAbstract=null), Reference(id=1329527204263867097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Vultaggio A, Nencini F, Bormioli S, et al. Low dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis[J]. Allergy Asthma Immunol Res, 2020, 12(5): 885-893., articleTitle=null, refAbstract=null), Reference(id=1329527204343558874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Bettiol A, Urban ML, Dagna L, et al. Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study[J]. Arthritis Rheumatol, 2022, 74(2): 295-306., articleTitle=null, refAbstract=null), Reference(id=1329527204423250651, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Canzian A, Venhoff N, Urban ML, et al. Use of biologics to treat relapsing and/or refractory eosinophilic granulomatosis with polyangiitis: data from a European collaborative study[J]. Arthritis Rheumatol, 2021, 73(3): 498-503., articleTitle=null, refAbstract=null), Reference(id=1329527204532302556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Curtis C, Ogbogu P. Hypereosinophilic syndrome[J]. Clin Rev Allergy Immunol, 2016, 50(2): 240-251., articleTitle=null, refAbstract=null), Reference(id=1329527204624577245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Reiter A, Lefevre G, Cid MC, et al. Association between baseline therapy and flare reduction in mepolizumab-treated patients with hypereosinophilic syndrome[J]. Front Immunol, 2022, 13: 840974., articleTitle=null, refAbstract=null), Reference(id=1329527204704269022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Rothenberg ME, Roufosse F, Faguer S, et al. Mepolizumab reduces hypereosinophilic syndrome flares irrespective of blood eosinophil count and interleukin-5[J]. J Allergy Clin Immunol Pract, 2022, 10(9): 2367-2374., articleTitle=null, refAbstract=null), Reference(id=1329527204779766495, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Pane F, Lefevre G, Kwon N, et al. Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome[J]. Front Immunol, 2022, 13: 935996., articleTitle=null, refAbstract=null), Reference(id=1329527204867846880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Gleich GJ, Roufosse F, Chupp G, et al. Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study[J]. J Allergy Clin Immunol Pract, 2021, 9(12): 4431-4440., articleTitle=null, refAbstract=null), Reference(id=1329527204947538657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics[J]. Eur Respir J, 2014, 44(6): 1697-1700., articleTitle=null, refAbstract=null), Reference(id=1329527205023036130, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease[J]. N Engl J Med, 2017, 377(17): 1613-1629., articleTitle=null, refAbstract=null), Reference(id=1329527205094339299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Condreay LD, Gao C, Bradford E, et al. No genetic associations with mepolizumab efficacy in COPD with peripheral blood eosinophilia[J]. Respir Med, 2019, 155: 26-28., articleTitle=null, refAbstract=null), Reference(id=1329527205165642468, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Dasgupta A, Kjarsgaard M, Capaldi D, et al. A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis[J]. Eur Respir J, 2017, 49(3): 1602486., articleTitle=null, refAbstract=null), Reference(id=1329527205236945637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Isoyama S, Ishikawa N, Hamai K, et al. Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: a retrospective observational study[J]. Respir Investig, 2021, 59(4): 478-486., articleTitle=null, refAbstract=null), Reference(id=1329527205312443110, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Tuttle KL, Buchheit KM, Laidlaw TM, et al. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease[J]. J Allergy Clin Immunol Pract, 2018, 6(3): 1045-1047., articleTitle=null, refAbstract=null), Reference(id=1329527205404717799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Mahdavinia M, Batra PS, Codispoti C. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case[J]. Ann Allergy Asthma Immunol, 2019, 123(3): 311-312., articleTitle=null, refAbstract=null), Reference(id=1329527205480215272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Martin H, Barrett NA, Laidlaw T. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: a case series[J]. J Allergy Clin Immunol Pract, 2021, 9(3): 1384-1385., articleTitle=null, refAbstract=null), Reference(id=1329527205580878569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial[J]. Gut, 2010, 59(1): 21-30., articleTitle=null, refAbstract=null), Reference(id=1329527205656376042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Simon D, Yousefi S, Cazzaniga S, et al. Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study[J]. Allergy, 2020, 75(3): 669-672., articleTitle=null, refAbstract=null), Reference(id=1329527205731873515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Kang EG, Narayana PK, Pouliquen IJ, et al. Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis[J]. Allergy, 2020, 75(4): 950-953., articleTitle=null, refAbstract=null), Reference(id=1329527205803176684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Altman MC, Lenington J, Bronson S, et al. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis[J]. J Allergy Clin Immunol Pract, 2017, 5(4): 1137-1139., articleTitle=null, refAbstract=null), Reference(id=1329527205882868461, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Tomomatsu K, Sugino Y, Okada N, et al. Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment[J]. Allergol Int, 2020, 69(4): 636-638., articleTitle=null, refAbstract=null), Reference(id=1329527205958365934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Takeshita Y, Nobuyama S, Kanetsuna Y, et al. Eosinophilic bronchiolitis successfully treated with mepolizumab[J]. J Allergy Clin Immunol Pract, 2020, 8(3): 1159-1161., articleTitle=null, refAbstract=null), Reference(id=1329527206033863407, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=To M, Kono Y, Yamawaki S, et al. A case of chronic eosinophilic pneumonia successfully treated with mepolizumab[J]. J Allergy Clin Immunol Pract, 2018, 6(5): 1746-1748., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.05.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.05.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.05.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1715270400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
美泊利单抗在嗜酸性粒细胞增多疾病的治疗进展
张学兰 , 叶小萌 , 赵健 , 孟静
世界临床药物 | 综述评论 2024,45(5): 549-554
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (5) : 549 -554
美泊利单抗在嗜酸性粒细胞增多疾病的治疗进展
全屏
[Author(id=1329527199792738996, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527199968899766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527199792738996, language=EN, stringName=Xuelan ZHANG, firstName=Xuelan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200077951671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527199792738996, language=CN, stringName=张学兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio={"content":"

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

"}, bioImg=null, bioContent=

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200153449145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200237335227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200153449145, language=EN, stringName=Xiaomeng YE, firstName=Xiaomeng, middleName=null, lastName=YE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200312832700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200153449145, language=CN, stringName=叶小萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200413495998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200505770688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200413495998, language=EN, stringName=Jian ZHAO, firstName=Jian, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200593851073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200413495998, language=CN, stringName=赵健, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])]), Author(id=1329527200665154243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527200770011845, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200665154243, language=EN, stringName=Jing MENG, firstName=Jing, middleName=null, lastName=MENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527200900035270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, authorId=1329527200665154243, language=CN, stringName=孟静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=武警安徽省总队医院呼吸内科,安徽 合肥 230041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527199692075696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, xref=null, ext=[AuthorCompanyExt(id=1329527199700464305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China), AuthorCompanyExt(id=1329527199708852914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527197683004077, companyId=1329527199692075696, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=武警安徽省总队医院呼吸内科,安徽 合肥 230041)])])]
张学兰, 叶小萌, 赵健, 孟静
作者信息
  • 武警安徽省总队医院呼吸内科,安徽 合肥 230041
作者简介:

张学兰,主治医生,研究方向:呼吸系统疾病的诊治。

Advances in the treatment of eosinophilia related diseases with mepolizumab
Xuelan ZHANG, Xiaomeng YE, Jian ZHAO, Jing MENG
Affiliations
  • Department of Respiratory, Armed Police Force Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China
出版时间: 2024-05-10 doi: 10.13683/j.wph.2024.05.017
文章导航
收藏切换

嗜酸性粒细胞增多相关疾病较多,其病因不同,治疗方案也不相同,非感染和非肿瘤嗜酸性粒细胞增多相关疾病的一线治疗大多为糖皮质激素,根据病情轻重可联合免疫抑制剂治疗。美泊利单抗(mepolizumab)是一种人源抗白介素-5单克隆抗体,目前已被美国FDA批准用于慢性鼻-鼻窦炎伴鼻息肉(Chronic sinusitis with nasal polyps)、嗜酸性肉芽肿多血管炎(eosinophilic granulomatosis with polyangiitis)及高嗜酸性粒细胞综合征(hypereosinophilic syndrome)的二线治疗。现就美泊利单抗治疗除支气管哮喘(bronchial asthma)外相关嗜酸性粒细胞的应用研究进展作综述。

嗜酸性粒细胞增多  /  美泊利珠单抗  /  临床应用

There are many eosinophilia-related diseases, with different etiologies and different therapeutic programs. The first-line treatment for non-infectious and non-tumor-related eosinophilia-related diseases is mostly glucocorticoids, which can be combined with immunosuppressive agents according to the severity of the disease. Mepolizumab is a human anti-interleukin-5 monoclonal antibody which has been approved by the FDA for second-line treatment for chronic sinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. This article reviewed the research progress of mepolizumab in the application of eosinophilia-related diseases except bronchial asthma.

eosinophilia  /  mepolizumab  /  clinical application
张学兰, 叶小萌, 赵健, 孟静. 美泊利单抗在嗜酸性粒细胞增多疾病的治疗进展. 世界临床药物, 2024 , 45 (5) : 549 -554 . DOI: 10.13683/j.wph.2024.05.017
Xuelan ZHANG, Xiaomeng YE, Jian ZHAO, Jing MENG. Advances in the treatment of eosinophilia related diseases with mepolizumab[J]. World Clinical Drug, 2024 , 45 (5) : 549 -554 . DOI: 10.13683/j.wph.2024.05.017

参考文献 引证文献
排序方式:
[1]
王子熹. 嗜酸性粒细胞增多综合征的诊断与治疗[J]. 中华临床免疫与变态反应杂志, 2021, 15(1): 108-109.
[2]
夏训明. 美国FDA批准Nucala (mepolizumab/美泊利单抗)用于治疗嗜酸性粒细胞综合征[J]. 广东药科大学学报, 2020, 36(5): 746.
[3]
Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Respir Med, 2021, 9(10): 1141-1153.
[4]
Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis[J]. N Engl J Med, 2017, 376(20): 1921-1932.
[5]
Roufosse F, Kahn JE, Rothenberg ME, et al. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phaseⅢ, randomized, placebo-controlled trial[J]. J Allergy Clin Immunol, 2020, 146(6): 1397-1405.
[6]
Pavord ID, Bel EH, Bourdin A, et al. From DREAM to REALITI-A and beyond: mepolizumab for the treatment of eosinophil-driven diseases[J]. Allergy, 2022, 77(3): 778-797.
[7]
Fokkens WJ, Viskens AS, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023[J]. Rhinology, 2023, 61(3): 194-202.
[8]
Bachert C, Sousa AR, Han JK, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count[J]. J Allergy Clin Immunol, 2022, 149(5): 1711-1721.
[9]
Fokkens WJ, Mullol J, Kennedy D, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): in-depth sinus surgery analysis[J]. Allergy, 2023, 78(3): 812-821.
[10]
Hopkins C, Han JK, Lund VJ, et al. Evaluating treatment response to mepolizumab in patients with severe CRSwNP[J]. Rhinology, 2023, 61(2): 108-117.
[11]
Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016, 75(9): 1583-1594.
[12]
Ennis D, Lee JK, Pagnoux C. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis[J]. Expert Opin Biol Ther, 2019, 19(7): 617-630.
[13]
Vultaggio A, Nencini F, Bormioli S, et al. Low dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis[J]. Allergy Asthma Immunol Res, 2020, 12(5): 885-893.
[14]
Bettiol A, Urban ML, Dagna L, et al. Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study[J]. Arthritis Rheumatol, 2022, 74(2): 295-306.
[15]
Canzian A, Venhoff N, Urban ML, et al. Use of biologics to treat relapsing and/or refractory eosinophilic granulomatosis with polyangiitis: data from a European collaborative study[J]. Arthritis Rheumatol, 2021, 73(3): 498-503.
[16]
Curtis C, Ogbogu P. Hypereosinophilic syndrome[J]. Clin Rev Allergy Immunol, 2016, 50(2): 240-251.
[17]
Reiter A, Lefevre G, Cid MC, et al. Association between baseline therapy and flare reduction in mepolizumab-treated patients with hypereosinophilic syndrome[J]. Front Immunol, 2022, 13: 840974.
[18]
Rothenberg ME, Roufosse F, Faguer S, et al. Mepolizumab reduces hypereosinophilic syndrome flares irrespective of blood eosinophil count and interleukin-5[J]. J Allergy Clin Immunol Pract, 2022, 10(9): 2367-2374.
[19]
Pane F, Lefevre G, Kwon N, et al. Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome[J]. Front Immunol, 2022, 13: 935996.
[20]
Gleich GJ, Roufosse F, Chupp G, et al. Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study[J]. J Allergy Clin Immunol Pract, 2021, 9(12): 4431-4440.
[21]
Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics[J]. Eur Respir J, 2014, 44(6): 1697-1700.
[22]
Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease[J]. N Engl J Med, 2017, 377(17): 1613-1629.
[23]
Condreay LD, Gao C, Bradford E, et al. No genetic associations with mepolizumab efficacy in COPD with peripheral blood eosinophilia[J]. Respir Med, 2019, 155: 26-28.
[24]
Dasgupta A, Kjarsgaard M, Capaldi D, et al. A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis[J]. Eur Respir J, 2017, 49(3): 1602486.
[25]
Isoyama S, Ishikawa N, Hamai K, et al. Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: a retrospective observational study[J]. Respir Investig, 2021, 59(4): 478-486.
[26]
Tuttle KL, Buchheit KM, Laidlaw TM, et al. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease[J]. J Allergy Clin Immunol Pract, 2018, 6(3): 1045-1047.
[27]
Mahdavinia M, Batra PS, Codispoti C. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case[J]. Ann Allergy Asthma Immunol, 2019, 123(3): 311-312.
[28]
Martin H, Barrett NA, Laidlaw T. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: a case series[J]. J Allergy Clin Immunol Pract, 2021, 9(3): 1384-1385.
[29]
Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial[J]. Gut, 2010, 59(1): 21-30.
[30]
Simon D, Yousefi S, Cazzaniga S, et al. Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study[J]. Allergy, 2020, 75(3): 669-672.
[31]
Kang EG, Narayana PK, Pouliquen IJ, et al. Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis[J]. Allergy, 2020, 75(4): 950-953.
[32]
Altman MC, Lenington J, Bronson S, et al. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis[J]. J Allergy Clin Immunol Pract, 2017, 5(4): 1137-1139.
[33]
Tomomatsu K, Sugino Y, Okada N, et al. Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment[J]. Allergol Int, 2020, 69(4): 636-638.
[34]
Takeshita Y, Nobuyama S, Kanetsuna Y, et al. Eosinophilic bronchiolitis successfully treated with mepolizumab[J]. J Allergy Clin Immunol Pract, 2020, 8(3): 1159-1161.
[35]
To M, Kono Y, Yamawaki S, et al. A case of chronic eosinophilic pneumonia successfully treated with mepolizumab[J]. J Allergy Clin Immunol Pract, 2018, 6(5): 1746-1748.
2024年第45卷第5期
16
0
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.05.017
  • 接收时间:2023-11-23
  • 首发时间:2026-11-17
  • 出版时间:2024-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-11-23
基金
作者信息
    武警安徽省总队医院呼吸内科,安徽 合肥 230041
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏